The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R) - Wikidata - wikimedia - TriplyDB

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

http://www.wikidata.org/entity/Q33762930

about

The dopamine hypothesis of schizophrenia: version III--the final common pathway Age of onset of mental disorders: a review of recent literature The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments Twelve-month prevalence and treatment gap for common mental disorders: Findings from a large-scale epidemiological survey in India Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease Animal models of gene-environment interactions in schizophrenia.Epigenetic Alterations Associated with War Trauma and Childhood Maltreatment.Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study.The prevalence and profile of non-affective psychosis in the Nigerian Survey of Mental Health and Wellbeing.Comorbidity of severe psychotic disorders with measures of substance use Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia.Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry.Pattern recognition and functional neuroimaging help to discriminate healthy adolescents at risk for mood disorders from low risk adolescents The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.Perceived threat mediates the relationship between psychosis proneness and aggressive behavior.Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.Recording of severe mental illness in United Kingdom primary care, 2000-2010.Chronic medical conditions among jail detainees in residential psychiatric treatment: a latent class analysis A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia.Case report of visual hallucinations in anxiety.Advanced paternal age and risk of psychotic-like symptoms in adult offspring.Absence of bias in clinician ratings of everyday functioning among African American, Hispanic and Caucasian patients with schizophrenia Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population.Psychological disturbances and quality of life in obese and infertile women and men Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication.Psychiatric epidemiology: challenges and opportunities.Feedback on SMS reminders to encourage adherence among patients taking antipsychotic medication: a cross-sectional survey nested within a randomised trial.Examining the overlap between bipolar disorder, nonaffective psychosis, and common mental disorders using latent class analysis Cost-effectiveness of atypical antipsychotic medications versus conventional medication.Osteoporosis and fracture risk in people with schizophrenia Measurement invariance of the Social Phobia and Anxiety Inventory Violence and mental illness: what is the true story?Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.When functional capacity and real-world functioning converge: the role of self-efficacy.

P2860

Q22242827-C49478DA-65C0-4CEA-B2AF-578F58B7657A Q24669789-ECEA0749-B9E9-44C8-8B14-158E098EB0DC Q24670210-ACC37715-323A-478B-8FC3-87F11FC82CF8 Q26739664-503D3C7B-83F5-4A29-8F26-E658563B4CF0 Q26799270-C718980A-9824-4EFB-8878-679C7F3A2B9B Q28083651-AB488B2D-894A-470C-80A5-E6079F48511C Q28236815-51F355C7-817E-4B05-BE49-B411BF0A3826 Q30376941-BB4C95EE-7150-4F79-A409-C06C1079986B Q30432438-B76B22A6-5ED1-47F4-B94F-07E18505D3F9 Q30478272-A26109E9-0BD8-440C-BAA7-3FEB233142CB Q33361485-E4267034-F254-4E0B-8650-1994455355E8 Q33464064-72E91093-F044-45C1-BCC6-9A90C257EF6A Q33631841-4A340806-99DB-4831-B27F-F247C8329E7A Q33767822-C844E65F-0EEE-4492-A4F4-71E3334FAA58 Q33799120-B84BD689-A420-49A7-9AF0-F1FF535B3256 Q34119330-4B48BC6A-7ED1-4A57-8633-C9FE667393D1 Q34130842-0782727C-2CCF-4F57-881D-E378F756EEC8 Q34166129-C39D371D-C43A-42F7-BE94-1B151D923DC2 Q34531537-59F8536D-D128-4E23-AB27-EC881CA9B0A5 Q34586694-9B53DBC7-1882-4AF6-80C9-8E3E33B8487D Q34610068-B2369642-6BF3-4EF4-B3BD-3E87E43616F7 Q35065388-9F59B9C0-7641-4FA4-8DB8-542B3821B957 Q35070219-68C5D35E-7FA8-427D-95ED-63A6434E562C Q35168892-821DA093-0EFD-4D3C-BF2D-1A6DE5855176 Q35529636-F914411A-365C-44B3-A99B-47539160B950 Q35740686-45412F41-80A0-4B4E-BCB7-FC235ED390BE Q35755701-10916AE7-25F6-44D4-A30F-2AEFF16BEF58 Q35988529-D0A26D27-EFCD-4934-8A04-824A469882E2 Q36092716-0C84D527-CA4E-4E6A-B75B-44631970B38C Q36111278-CC5FE936-FDAE-4B0B-91AA-0148050ED76E Q36176732-F3013206-685C-415F-A462-954BE165BB76 Q36275681-816FE51B-2D90-4017-AF9B-4A9E18125923 Q36302773-ABD8C34F-C473-4882-ABEA-452B7F517B81 Q36312830-2B5110AA-FCE6-4D25-8D5F-91F598393DFE Q36573896-B2497D30-94DE-4E70-8D89-DD4E6F3E0AAE Q36592205-B0B9F23E-C6A2-48A4-B6E7-2A2AA5486AF9 Q36625475-0CF1A241-B59A-4E6C-A2BB-BC271482BAAB Q36682234-6C409D09-5C9C-4127-8598-57B2B38F6DBE Q36902087-4782B4C7-439B-4BF4-B2FC-AA5C0A577F53 Q36940002-6352C757-66CF-4789-BF16-16CC147AEF8D

P2860

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

http://www.wikidata.org/entity/Q33762930

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

The prevalence and correlates ...... ity Survey Replication (NCS-R)

@ast

The prevalence and correlates ...... ity Survey Replication (NCS-R)

@en

type

label

The prevalence and correlates ...... ity Survey Replication (NCS-R)

@ast

The prevalence and correlates ...... ity Survey Replication (NCS-R)

@en

prefLabel

The prevalence and correlates ...... ity Survey Replication (NCS-R)

@ast

The prevalence and correlates ...... ity Survey Replication (NCS-R)

@en

P1433

Q33762930-DFBE49F7-7993-45D6-B1BD-CB541E54454A

P1476

Q33762930-1AED78EB-6504-4CF4-B8C5-EDCB74FAF67A

P2093

Q33762930-007F0CBB-E0A8-4AD6-B2BC-8916E9C726EA

Q33762930-3864083E-3B06-4DB2-A093-6DE6DB9A63AB

Q33762930-8BE77673-4919-4942-B6C4-D49436B633EF

Q33762930-A07D7A69-34F5-446C-A313-CE2CB79CAB3B

Q33762930-A57E955C-D963-4ED7-B890-08618C31B3A3

Q33762930-DBFEEF92-13B6-41CA-BD46-C987CB05966B

Q33762930-EFE72681-28F1-45CE-BCE1-509BC95E8F73

P2860

Q33762930-013F88BA-7E4D-4C48-BA74-8B399DCDF61A

Q33762930-10D85324-EA01-47FE-9565-848E5738CBA9

Q33762930-1730F5DD-21DC-44C7-B114-386E66BAC3ED

Q33762930-220FB225-B7B0-48E6-8098-88AEC86EADE5

Q33762930-2ECA51DC-2632-4A4B-9F70-2F190D8C564C

Q33762930-2FB7E393-B04A-4197-961E-C64F3ED93748

Q33762930-2FFE398D-8F0E-4D06-AB6C-A357DA52A619

Q33762930-3781031B-ABFB-48C5-B184-7FFD5E5FE052

Q33762930-3B1EBE6A-0663-4166-B901-CACF23CF8AD6

Q33762930-4469120A-B82A-4FBD-A033-1EA67D2613A8

P304

Q33762930-79D241F7-4257-4C56-AE29-3E9285544DAB

P31

Q33762930-C0108508-5341-462C-A0EE-1AF33708F7BB

P356

Q33762930-EB39FA07-13B4-40EC-9DE5-414800662B4F

P407

Q33762930-46F12896-F2EF-4C9F-943F-7F80EF0778D8

P433

Q33762930-AC3058B8-F17C-422F-A1E5-F5CA41B9F4B3

P478

Q33762930-39BB7385-32AF-4D54-A091-C056576A5033

P50

Q33762930-47536CED-69AD-4C9A-9942-EB35C88BA0F1

Q33762930-BB2AC916-E2BB-4366-B03E-59D13CF9B5E5

Q33762930-E44347A6-D60D-4731-83E9-F844729D2D03

Q33762930-FC832C68-1E4E-42A7-9714-5A314B2C1A75

P577

Q33762930-B34A3FA2-8774-48EC-96BE-92051B215516

P5875

Q33762930-FFBF754D-3620-45F7-BC4F-A8BC1182B675

P698

Q33762930-C0C6D675-BAFA-4018-84AE-7F5B9D8AE18C

P921

Q33762930-32C437B3-7F52-473B-8D10-11312D2C8022

P932

Q33762930-355FB6FA-FA70-405A-ADDE-958462D4E594

P356

J.BIOPSYCH.2005.04.034

P1433

Biological Psychiatry

P1476

The prevalence and correlates ...... ity Survey Replication (NCS-R)

@en

P2093

Elizabeth Gagnon

http://www.w3.org/2001/XMLSchema#string

Ellen Walters

http://www.w3.org/2001/XMLSchema#string

Howard Birnbaum

http://www.w3.org/2001/XMLSchema#string

Ian R H Falloon

http://www.w3.org/2001/XMLSchema#string

Lizheng Shi

http://www.w3.org/2001/XMLSchema#string

Margaret Guyer

http://www.w3.org/2001/XMLSchema#string

Mary J Howes

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology

Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country Study

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Epidemiology of schizophrenia: the global burden of disease and disability.

The National Comorbidity Survey Replication (NCS-R): background and aims.

The US National Comorbidity Survey Replication (NCS-R): design and field procedures.

The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures.

The epidemiology of alcohol, drug, and mental disorders among homeless persons.

P304

668-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2005.04.034

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth S. Kendler

Ronald C. Kessler

P577

2005-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7720436

http://www.w3.org/2001/XMLSchema#string

P698

16023620

http://www.w3.org/2001/XMLSchema#string

P921

P932

2847859

http://www.w3.org/2001/XMLSchema#string